SCHEMBL6477431

SCHEMBL6477431

COCNC(=O)c1csc(N(C(=O)c2ccccc2Cl)c2ccc(C)c(C)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
S1PR1 P21453 1/20 0.36
MAPT P10636 4/20 0.36
NPSR1 Q6W5P4 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ABCB1 P08183 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 2/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RXFP1 Q9HBX9 2/20 0.34
PTPRB P23467 2/20 0.34
HIF1A Q16665 1/20 0.33
PANK3 Q9H999 1/20 0.33
LMNA P02545 1/20 0.33
DHODH Q02127 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038949 0.89 MAPT (0.40) KDM4ES1PR1MAPTNPSR1ALDH1A1
SCHEMBL5032672 0.89 TLR7 (0.40) KDM4ES1PR1MAPTNPSR1HTT
SCHEMBL6477435 0.83 KDM4E (0.40) KDM4ES1PR1MAPTNPSR1ALDH1A1
SCHEMBL5034783 0.81 CYP3A4 (0.43) KDM4EMAPTNPSR1ALDH1A1L3MBTL1
SCHEMBL5032635 0.79 FLT1 (0.40) MAPTNPSR1ALDH1A1HTTLMNA
SCHEMBL5035133 0.78 HPGD (0.47) KDM4EMAPTNPSR1ALDH1A1POLB
SCHEMBL5035887 0.75 KDM4E (0.39) KDM4EMAPTNPSR1ALDH1A1L3MBTL1
SCHEMBL5041310 0.75 CES2 (0.37) KDM4ES1PR1MAPTNPSR1ALDH1A1
SCHEMBL5034756 0.75 HPGD (0.43) MAPTNPSR1ALDH1A1MAPK1L3MBTL1
SCHEMBL5032679 0.74 LMNA (0.47) KDM4EMAPTNPSR1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 KDM4E 3200/4885S1PR1 316/4885MAPT 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.